Urinary markers for prostate cancer. (Q36648053)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

Urinary markers for prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

Stephen R. Pennington

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Michelle R Downes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Jennifer C Byrne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Michael J Dunn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

John M Fitzpatrick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

R William G Watson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

263-268

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json

Prostate cancer detection at low prostate specific antigen

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

DNA-based detection of prostate cancer in urine after prostatic massage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

uPM3, a new molecular urine test for the detection of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

The expression and significance of survivin mRNA in urinary bladder carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Use of thymosin beta15 as a urinary biomarker in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Thymosin beta 15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

A preliminary study of urinary transferrin as a marker for prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Preliminary evaluation of 5α-reductase type 2 in urine as a potential marker for prostate disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

Noninvasive detection of genetic instability in cells from prostatic secretion as a marker of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06610.X

10.1111/J.1464-410X.2006.06610.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17092277%20AND%20SRC:MED&resulttype=core&format=json